LEXINGTON, Mass.--(BUSINESS WIRE)-- Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it will report its financial results for the year ended December 31, 2014 on Friday, February 27, 2015 before the US financial markets open. The Company will host a conference call and webcast at 8:30 a.m. ET to discuss 2014 financial results and provide a business update. Individuals interested in participating in the call should dial (855) 354-1855 (U.S. and Canada) or (484) 365-2865 (International).
A live webcast may be accessed in the Investors section of the Company's website at www.concertpharma.com. Please log on to the Concert website approximately 15 minutes prior to the scheduled webcast to ensure adequate time for any software downloads that may be required. A replay of the webcast will be available on Concert's website for three months.
I note that Roger has taken up on right to buy.
Sec Form 4
Date of Earliest Transaction 2/17/2015
Name and Address of Reporting Person *
Tung Roger D
Employee Stock Option (right to buy) executed 28495 shares.
Yes I agree it is nice to be amongst friends from AVNR.
As soon as AVNR tied in with CNCE I started reading up on them and also read a good number of posts on this message board. As one would expect there is a good number of existing knowledgably posters here.
In the early period of my reading I noted GSK were in the mix so as to speak, I noted that they agreement came to an end. I’m going to have to check this out for confirmation but I recall reading up on some of GSK stock purchases recently, one being shares of CNCE, that pricked my ears up at the time. When I get a moment I will look for confirmation. Just to add regarding GSK at the time mentioned, I thought it was odd that AVNR, GSK and CNCE were in a way related.
James’s appointment is an interesting forward looking move.
Hi Onlyfacts – we have not conversed in a while, trust you are keeping well, all is great this side.
Thank you for the information. Yes I agree James appears to be an asset based on his previous position.
Just thinking out aloud and giving consideration to Alexa making inhaled system for established drugs. The same reminds me of Opti and the possible ongoing developments to that effect. Granted it is not exactly on the same lines, but if it was would that increase Otsuka interest in CNCE something else for me to ponder on perhaps !
Hi Morninggas – once again thank you for the heads up.
You may have had a chance to see my reply to your good self before Yahoo deleted it. I tried to post it again but it would not stay posted. I was only elaborating on your original post, most of the contents I posted can be found on their web site anyway as you will know well. I noted they have added another video update also.
Once again thank you for the heads up in the first instance.
PS Will not be long before the 28th Feb comes around ;-)